Oncobiologics Inc. appointed Joerg Windisch as director, effective March 23.
He was appointed to fill the vacancy created by Yezan Haddadin's resignation from the board, the company said March 27 in an SEC filing.
Windisch is currently COO of Polpharma Biologics.
Cranbury, N.J.-based Oncobiologics is a clinical-stage biopharmaceutical company which focuses on developing biosimilars in immunology and oncology disease areas.